After the business requested an immediate administrative stay, a federal appeals court Friday suspended the FDA’s prohibition on Juul products. The e-cigarette manufacturer’s access to the American market was essentially terminated on Thursday after the American regulator initiated broad action against it.
The court filings state that the interim stay “should not be regarded in any way as a judgement on the merits” and that its main purpose is to purchase time until the matter can be properly considered by the court.
After Juul failed to give sufficient proof that its products were safe enough substitutes for smoking, the FDA initiated action against the firm. The regulatory body said that it has “serious issues” about Juul’s documents.
The Wall Street Journal reported that Juul is contemplating declaring bankruptcy if the FDA’s injunction is not overturned.
After the FDA issued its order, Juul Chief Regulatory Officer Joe Murillo said that the business would seek a stay and that it intended to challenge the regulator’s ruling.
“We believe that we adequately characterised the toxicological profile of JUUL products in our applications, which we submitted more than two years ago, including comparisons to combustible cigarettes and other vapour products, and believe this data, along with the totality of the evidence, meets the statutory standard of being “appropriate for the protection of the public health,” said Murillo.
Reynolds American and NJOY Holdings, competitors of Juul, will keep selling their own vape products in the United States after obtaining the FDA approval that Juul was unable to get.
Subtly charming pop culture geek. Amateur analyst. Freelance tv buff. Coffee lover